@article{a2c2ce95bb134ff4afe2b70eaa976bea,
title = "Nine years of comparative effectiveness research education and training: Initiative supported by the PhRMA Foundation",
abstract = "The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term 'patient-centered outcomes research' (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.",
keywords = "centers of excellence, comparative effectiveness research, patient-centered outcomes research",
author = "Devine, {Emily Beth} and Eleanor Perfetto and Pickard, {A. Simon} and Schumock, {Glen T.} and Segal, {Jodi B.} and Eileen Cannon and Gagnon, {Jean Paul} and Brixner, {Diana I.} and Garrison, {Louis P.} and Murray, {Michael D.}",
note = "Funding Information: Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation Funding Information: In 2013, the directors of the first two CER Centers of Excellence that were funded (UW, Hopkins), joined with E Cannon and JP Gagnon to plan a national invitational conference intended to strengthen the proposed elements of a CER/PCOR curriculum and to allow the funded centers to share their experiences in implementing these in real-world and diverse academic settings. Funding for the conference was provided by a small conference grant awarded by AHRQ (PI: Segal), and a similar grant from PCORI (PI: Cannon). The PhRMA Foundation also supported the conference. Invited stakeholders were 120 key individuals from academia, educational accrediting bodies, industry, federal and state governments, professional societies, and the private sector; together, representing over 50 organizations. Attendees convened at the offices of the Pew Charitable Trust in January 2014 to address the five conference objectives: review existing competencies proposed for CER; describe existing curricula used to achieve these competencies; identify curricular enhancements; identify workforce needs; and discuss unique methodologic issues of CER unaddressed by related disciplines. Funding Information: Funding for the second invitational conference was again provided by the PhRMA Foundation, this time with in-kind support from AMCP. The conference planning committee was led by the directors of the UIC Center of Excellence (Schumock and Pickard), assisted by Dr Perfetto (University of Maryland, MD, USA), along with E Cannon, JP Gagnon, a faculty liaison from the first conference (Devine) and a representative from AMCP (Saha). As the conference title makes clear, the conference focused on enhancing the uptake and use of CER/PCOR by patients, clinicians and payers. Details of the conference proceedings are found in the two companion papers in this series [16,17]. Funding Information: • This report describes the unique initiative of the Pharmaceutical Manufacturers Research and Manufacturers Association of America (PhRMA) Foundation, which provided grant funding to seed six academic Centers of Excellence in CER/PCOR, and spearheaded and sponsored three national invitational conferences to advance the conduct and use of CER. Funding Information: EB Devine, LP Garrison, E Perfetto, AS Pickard, GT Schumock, JB Segal and D Brixner are principal investigators for their respective CER Centers of Excellence, originally funded by the PhRMA Foundation. E Perfetto is an employee of the National Health Council, a multistakeholder membership organization that receives dues and sponsorship funding from a wide range of organizations. Members and sponsors are listed on the NHCouncil.org website. E Cannon is President of the PhRMA Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.",
year = "2018",
month = feb,
doi = "10.2217/cer-2017-0059",
language = "English (US)",
volume = "7",
pages = "167--175",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd.",
number = "2",
}